5,5-dibromo-2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one | 335654-07-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并嘧啶类
• 英文名称: 5,5-dibromo-2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one
• 英文别名: 5,5-dibromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-6-one
• CAS: 335654-07-4
• 化学式: C₆H₂Br₂ClN₃O
• 分子量: 327.362
• InChiKey: ZFKWOUKALUJVAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  54.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5,5-dibromo-2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one 在 palladium on activated charcoal 氢气 、 氯化铵 、 锌 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 20.0 ℃ 、344.74 kPa 条件下， 反应 0.5h， 生成 5,7-二氢-6H-吡咯并[2,3-d]嘧啶-6-酮
  参考文献：
  名称：

  Synthesis of 2-chloro-5,7-dihydro-6 H -pyrrolo[2,3- d ]pyrimidin-6-one

  摘要：

  1,3-Dihydro-2N-indol-3-ones (oxindoles) and 1,3-dihydro-2H-pyrrolopyridin-2-ones (azaoxindoles) are useful scaffolds that have been explored for various pharmaceutical uses. Herein we report the synthesis of 2-chloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one (5) and its derivatives, and the application of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones (diazaoxindoles) as novel scaffold to kinase research areas. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(00)02219-x
• 作为产物：
  描述：

  2-氯-5-(2,2-二甲氧基-乙基)-嘧啶-4-基胺 在 盐酸 、 pyridinium hydrobromide perbromide 作用下， 以 甲醇 、 叔丁醇 为溶剂， 生成 5,5-dibromo-2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one
  参考文献：
  名称：

  Synthesis of 2-chloro-5,7-dihydro-6 H -pyrrolo[2,3- d ]pyrimidin-6-one

  摘要：

  1,3-Dihydro-2N-indol-3-ones (oxindoles) and 1,3-dihydro-2H-pyrrolopyridin-2-ones (azaoxindoles) are useful scaffolds that have been explored for various pharmaceutical uses. Herein we report the synthesis of 2-chloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one (5) and its derivatives, and the application of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones (diazaoxindoles) as novel scaffold to kinase research areas. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(00)02219-x

文献信息

• [EN] cGAS ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DU CGAS
  申请人：IMMUNE SENSOR LLC

  公开号：WO2017176812A1

  公开（公告）日：2017-10-12

  Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

  揭示了一种新型化合物的化学式（I），这些化合物是cGAS拮抗剂，涉及到这些化合物的制备方法、包含这些化合物的药物组合物，以及它们在医学治疗中的应用。
• New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
  申请人：Laboratorios Almirall, S.A.

  公开号：EP2108641A1

  公开（公告）日：2009-10-14

  This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.

  这项发明涉及具有一般式(I)的新p38丝裂原活化蛋白激酶抑制剂；其制备方法；包含它们的药物组合物；以及它们在治疗中的应用。
• [EN] FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS<br/>[FR] DÉRIVÉS DE PHÉNYLQUINOLÉINONE EN TANT QU'INHIBITEURS DE L'ISOCITRATE DÉSHYDROGÉNASE MUTANTE
  申请人：FORMA THERAPEUTICS INC

  公开号：WO2016171755A1

  公开（公告）日：2016-10-27

  The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula (I) where A, B, U, V, Z, W1, W2, W3, and R1-R6 are described herein.

  该发明涉及抑制突变异柠檬酸脱氢酶（mt-IDH）蛋白具有新型活性，用于治疗细胞增殖紊乱和癌症，其化学式为（I），其中A、B、U、V、Z、W1、W2、W3和R1-R6如本文所述。
• SUBSTITUTED SPIRO[CYCLOALKYL-1,3'-INDOL]-2'(1'H)-ONE DERIVATIVES AND THEIR USE AS P38 MITOGEN-ACTIVATED KINASE INHIBITORS
  申请人：Eastwood Paul Robert

  公开号：US20110053936A1

  公开（公告）日：2011-03-03

  The present disclosure is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

  本公开涉及新的p38丝裂原活化蛋白激酶抑制剂，其具有一般式(I)，其制备方法，其药物组合物以及其使用方法。
• NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS
  申请人：GRÜNENTHAL GMBH

  公开号：US20160152624A1

  公开（公告）日：2016-06-02

  Novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

  本发明涉及一种通式（I）的新型替代的浓缩嘧啶化合物，其中化学基团、取代基和指数如描述中所定义，并且涉及其作为药物的用途，特别是作为治疗可以通过抑制PDE4酶来治疗的疾病和病症的药物。